Arkuda Therapeutics

About:

Arkuda Therapeutics is a pharmaceutical company.

Website: https://www.arkudatx.com/

Twitter/X: ArkudaTx

Top Investors: Mission BioCapital, Eli Lilly, Cormorant Asset Management, Atlas Venture, Surveyor Capital

Description:

Arkuda Therapeutics is a biotechnology company leveraging new insights into progranulin and lysosomal biology to develop medicines to change the trajectory of neurodegenerative disease. Arkuda’s lead compounds aim to correct progranulin deficiency and lysosomal dysfunction in GRN-related frontotemporal dementia (FTD-GRN), a genetically-defined subtype of frontotemporal dementia caused by an autosomal dominant mutation in the GRN gene.